**Phase:** 6.8 — Final Governance Decision Record  
**Mode:** `READ_ONLY GOVERNANCE DECISION RECORD PREPARATION`  
**Generated at (UTC):** `2026-08-21T06:53:33Z`  
**Author:** Manus AI  
**Decision state:** `GOVERNANCE_DECISION_READY — DESIGN-LEVEL ONLY`  
**Source boundary:** The five user-specified Phase 6.7/6.6 artifacts, with compatibility preserved against the existing Phase 6.8 governance acceptance record.

# SEG Internship Final Governance Decision Record

## 1. Purpose and decision boundary

This document consolidates the remaining SEG Internship governance recommendations into a controlled decision record. It records the recommendations as **design-level governance decisions only**. It does not constitute clinical approval, rights approval, canonical-source selection, canonical schema activation, schema conversion, JSON generation, database import, application exposure, learner-facing publication, or implementation authorization. The governing lifecycle remains `Source → Version → Governance Record → Clinical Review → Approval → Activation`. [1] [2] [3]

The selected statuses below preserve the design-level acceptance already recorded in the existing Phase 6.8 governance record. They do not expand that prior scope or infer a reviewer identity, clinical reviewer identity, rights reviewer identity, signature, credential, approval date, or implementation authority that is not explicitly supplied. [6]

> **Decision interpretation:** The recommendations may be used as controlled design references for the next evidence-closure stage. Source-derived medical records remain pending the separate provenance, rights, relevant-review, track/taxonomy, audit, QA, and implementation gates.

## 2. Decision status vocabulary

| Status | Meaning in this record |
|---|---|
| `ACCEPTED_AS_DESIGN_ONLY` | The package-level recommendation is accepted as a bounded design reference, not as execution authorization. |
| `DESIGN_DECISION_RECORDED` | The recommendation is recorded for controlled planning while its evidence and implementation gates remain open. |
| `DESIGN_CANDIDATE_ACCEPTED_NON_CANONICAL` | A candidate ordering is accepted for future comparison; it is not a canonical source decision. |
| `DESIGN_CONTRACT_ACCEPTED` | A contract boundary is accepted as a design reference; no canonical enum or schema amendment is activated. |
| `OPEN` | A required evidence or semantic closure remains outstanding. |
| `BLOCKED` | Missing, ambiguous, conflicting, or non-attributable evidence prevents the next controlled gate. |
| `NOT_AUTHORIZED` | The action is outside this phase and cannot be inferred from a design decision. |

## A) Package acceptance

### Recommendation

Accept the Phase 6.6 recommendation package as a coherent, reviewable design package covering the lineage crosswalk, the two duplicate-family ordering recommendations, and the three content-contract recommendations. Preserve the fail-closed interpretation: documentation completeness is not evidence closure and design acceptance is not clinical or production approval. [1] [2]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_DESIGN_ONLY` | Accept the package solely as a bounded design reference and continue evidence closure separately. |
| `RETURN_FOR_CLARIFICATION` | Return the package for clarification of scope, conditions, or unresolved decisions. |
| `BLOCK_PENDING_EVIDENCE` | Keep the package blocked until missing attributable evidence is supplied. |
| `REJECT_RECOMMENDATIONS` | Reject one or more recommendations with an attributable rationale and audit event. |

### Selected status field

`ACCEPTED_AS_DESIGN_ONLY`.

This status records the design-level package decision only. It does not close the individual evidence gates or authorize schema-revalidation execution.

### Required authority

An authorized SEG governance decision owner must own the package-level decision. Clinical review, rights review, taxonomy review, architecture/schema confirmation, and implementation authorization remain separate authorities and may not be inferred from package acceptance.

### Evidence basis

The evidence basis is the Phase 6.7 acceptance checklist, the Phase 6.7 gate report, the Phase 6.6 governance closure report, and the existing Phase 6.8 design-level acceptance record. These artifacts consistently preserve source identities, professional-track separation, and the distinction between recommendation, acceptance, approval, implementation, and activation. [1] [2] [3] [6]

### Conditions

The package must remain read-only and fail-closed. No unresolved provenance, version, rights, reviewer, track/taxonomy, audit, duplicate-comparison, lineage-namespace, contract, QA, or implementation blocker may be inferred as closed. Acceptance of the package does not accept every source-derived medical claim and does not make any content learner-facing.

### Audit requirements

The append-only audit event must record the decision-record identifier, actor or authority as supplied, role, timestamp, exact scope, evidence artifacts and hashes where available, decision option, selected status, rationale, conditions, unresolved issues, and the fact that the decision is design-level only. It must explicitly distinguish package acceptance from clinical approval, rights approval, schema activation, import authorization, release, and activation.

## B) `SRC-0078` lineage decision

### Recommendation

Preserve an append-only `CROSSWALK RELATIONSHIP` between the SEG inventory identifier `SRC-0078` and the source-local identifier `phone-pediatrics-main`, referring to the same observed file candidate without replacing either identifier. Preserve the original path `02_Internship/JMC_Exam_Practice/Sources_Phone/pediatrics-main.md` and the supplied SHA-256 `189768c49b5be2df0a537a92d8c0a55ec0ea016d4f34ac10b314965a6eb10eac`. [2] [4]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_CROSSWALK_AS_DESIGN_DECISION` | Record the relationship for traceability while preserving both identifiers. |
| `ACCEPT_AS_ALIAS` | Explicitly define the identifiers as aliases within a documented namespace model. |
| `ACCEPT_AS_DISTINCT_NAMESPACES` | Explicitly define both namespaces and the permitted relationship between them. |
| `RETURN_FOR_NAMESPACE_CLARIFICATION` | Request clarification before selecting alias or distinct-namespace semantics. |
| `BLOCK_LINEAGE_IDENTITY_CONFLICT` | Preserve both identifiers and stop candidate revalidation when identity evidence remains insufficient. |

### Selected status field

`CROSSWALK_RELATIONSHIP_ACCEPTED_AS_DESIGN_DECISION`.

This status does **not** select alias semantics over distinct namespaces. It does not authorize identifier substitution, canonicalization, normalization, or candidate revalidation.

### Required authority

An authorized source/governance reviewer with authority over source identity and namespace semantics must confirm the affected scope, namespace definitions, relationship meaning, and unresolved disposition. No authority is inferred from a filename, folder, or topic cue.

### Evidence basis

The lineage recommendation preserves both IDs, the immutable path, the file type, the exact SHA-256, and the observed source-local context. The Phase 6.7 checklist and gate report identify namespace semantics, provenance/version, rights, reviewer, track/taxonomy, and audit evidence as still open or blocked. [2] [4]

### Conditions

Both identifiers must remain unchanged and separately traceable. The source remains outside learner-facing exposure. Owner/publisher, governed version, access date, rights/display scope, explicit `02_Internship` evidence, taxonomy ID/version, relevant review, and append-only audit evidence must close independently. If the relationship cannot be supported, retain `BLOCKED_LINEAGE_IDENTITY_CONFLICT` and do not proceed to revalidation.

### Audit requirements

The audit event must capture both identifiers, both namespaces when known, exact path, SHA-256, affected records, relationship type, unresolved alias/distinct-namespace question, actor or authority as supplied, role, timestamp, rationale, evidence links, rollback treatment, and the prohibition on replacing either identifier.

## C) `DUP-DRUG-001` decision

### Recommendation

Record `Drug Essentials v2_Pack` as the `PRIMARY DESIGN CANDIDATE` for future authorized comparison while preserving Drug Essentials Base as historical lineage across `SRC-0023`, `SRC-0024`, and `SRC-0025`. Preserve the `v2_Pack` lineage across `SRC-0027`, `SRC-0028`, and `SRC-0029`. [2] [5]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_PRIMARY_DESIGN_CANDIDATE` | Accept `v2_Pack` as comparison priority without canonical selection. |
| `RETURN_FOR_FILE_COMPARISON` | Require readable content and structure comparison before recording a design ordering. |
| `KEEP_BLOCKED_PENDING_CANONICAL_REVIEW` | Preserve both lineages and defer any ordering or canonical treatment. |
| `SELECT_CANONICAL_SOURCE` | A separate future authorization would be required; it is outside this phase. |
| `ARCHIVE_DELETE_MERGE_OR_OVERWRITE` | Prohibited in this phase and requires separate rollback-safe authorization. |

### Selected status field

`DESIGN_CANDIDATE_ACCEPTED_NON_CANONICAL`.

The selected candidate is `Drug Essentials v2_Pack`; no canonical source, archive target, deletion, merge, overwrite, rename, or replacement is recorded.

### Required authority

An authorized source/governance reviewer must perform the independent duplicate review. A later canonical or archive decision would require separate authority and explicit rollback-safe authorization. Clinical, rights, taxonomy, and implementation authorities remain separate.

### Evidence basis

The duplicate recommendation identifies the two preserved lineages and the non-canonical `v2_Pack` ordering. It also records that a complete readable content/structure comparison, governed version evidence, owner/publisher, exact locators, rights/display scope, and reviewer outcome were not supplied. A `v2` filename signal is not governed version evidence. [2] [5]

### Conditions

Both lineages remain preserved and separately traceable. The selected candidate is only a priority for future comparison. No medical content may be rewritten or clinically adjudicated from the candidate label. Canonical selection and archive treatment remain blocked pending independent comparison and attributable decision evidence.

### Audit requirements

The audit event must identify `DUP-DRUG-001`, all source IDs and paths in both lineages, supplied SHA-256 values, comparison scope, overlap and structural findings when later available, version evidence, owner/publisher, rights/display decision, reviewer identity and role, timestamp, rationale, unresolved issues, rollback treatment, and non-canonical status.

## D) `DUP-EMERGENCY-001` decision

### Recommendation

Record `Emergency Cases v2_Pack` as the `PRIMARY DESIGN CANDIDATE` for future authorized comparison while preserving Emergency Cases Base as historical lineage across `SRC-0033`, `SRC-0034`, and `SRC-0035`. Preserve the `v2_Pack` lineage across `SRC-0037`, `SRC-0038`, and `SRC-0039`. [2] [5]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_PRIMARY_DESIGN_CANDIDATE` | Accept `v2_Pack` as comparison priority without canonical selection. |
| `RETURN_FOR_FILE_COMPARISON` | Require readable content and structure comparison before recording a design ordering. |
| `KEEP_BLOCKED_PENDING_CANONICAL_REVIEW` | Preserve both lineages and defer any ordering or canonical treatment. |
| `SELECT_CANONICAL_SOURCE` | A separate future authorization would be required; it is outside this phase. |
| `ARCHIVE_DELETE_MERGE_OR_OVERWRITE` | Prohibited in this phase and requires separate rollback-safe authorization. |

### Selected status field

`DESIGN_CANDIDATE_ACCEPTED_NON_CANONICAL`.

The selected candidate is `Emergency Cases v2_Pack`; no canonical source, archive target, deletion, merge, overwrite, rename, or replacement is recorded.

### Required authority

An authorized source/governance reviewer must perform the independent duplicate review. A later canonical or archive decision would require separate authority and explicit rollback-safe authorization. Clinical, rights, taxonomy, and implementation authorities remain separate.

### Evidence basis

The duplicate recommendation identifies the two preserved lineages and the non-canonical `v2_Pack` ordering. It also records that a complete readable content/structure comparison, governed version evidence, owner/publisher, exact locators, rights/display scope, and reviewer outcome were not supplied. A `v2` filename signal is not governed version evidence. [2] [5]

### Conditions

Both lineages remain preserved and separately traceable. The selected candidate is only a priority for future comparison. No medical content may be rewritten or clinically adjudicated from the candidate label. Canonical selection and archive treatment remain blocked pending independent comparison and attributable decision evidence.

### Audit requirements

The audit event must identify `DUP-EMERGENCY-001`, all source IDs and paths in both lineages, supplied SHA-256 values, comparison scope, overlap and structural findings when later available, version evidence, owner/publisher, rights/display decision, reviewer identity and role, timestamp, rationale, unresolved issues, rollback treatment, and non-canonical status.

## E) Clinical Case contract decision

### Recommendation

Accept the Clinical Case contract as a bounded design reference that preserves exact source sections and locators. Candidate fields remain bounded to the documented design, including `case_type`, source-derived sections, specialty/topic, pathway, and the common governance envelope. Missing sections remain missing; no presentation, reasoning, management, dose, contraindication, or reference may be invented. [3]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_DESIGN_CONTRACT` | Accept the bounded design for controlled planning only. |
| `RETURN_FOR_CONTRACT_CLARIFICATION` | Request clarification of field, required-field, or review-state semantics. |
| `BLOCK_PENDING_SCHEMA_AUTHORITY` | Keep the contract blocked until architecture/schema authority confirms it. |
| `REJECT_DESIGN_RECOMMENDATION` | Reject the recommendation with attributable rationale. |

### Selected status field

`DESIGN_CONTRACT_ACCEPTED`.

No canonical `case` enum, manifest amendment, schema activation, conversion, or production record is created.

### Required authority

Architecture/schema authority must confirm the contract identity/version, fields, required-field rules, unknown-field policy, review-state semantics, lineage requirements, track/taxonomy handling, and approval owner. Qualified clinical/relevant review and rights review remain independent gates for source-derived content.

### Evidence basis

The contract recommendation defines the source-fidelity boundary and explicitly states that the design is not a canonical enum or activated schema type. The Phase 6.7 gate report identifies contract authority, provenance, rights, track/taxonomy, reviewer, QA, and implementation evidence as still required. [1] [3]

### Conditions

The unchanged architecture and professional-track separation remain in force. Source-derived content remains `Pending Clinical Review` / `NOT_APPROVED` unless independent evidence later supplies another observed state. No medical facts may be generated from incomplete source material.

### Audit requirements

The audit event must record contract name, design version or identity when supplied, selected design status, authority, scope, field and boundary decisions, source-fidelity rule, review-state semantics, unresolved fields, evidence links, actor/role/timestamp, and explicit non-activation status.

## F) Skills / Procedures contract decision

### Recommendation

Accept the Skills / Procedures contract as a design reference with an explicit competency boundary. Framework candidates, individual skills, procedures, competencies, assessments, and sign-off records must remain distinct. A framework must not be treated as a completed competency, OSCE result, checklist, credential, or sign-off. [3]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_WITH_COMPETENCY_BOUNDARY` | Accept the design while preserving distinct record roles and explicit level/assessment semantics. |
| `RETURN_FOR_COMPETENCY_CLARIFICATION` | Request clarification of required level, assessment method, or sign-off semantics. |
| `BLOCK_PENDING_CONTRACT_AUTHORITY` | Keep the contract blocked pending architecture/schema and relevant educational review. |
| `REJECT_DESIGN_RECOMMENDATION` | Reject the recommendation with attributable rationale. |

### Selected status field

`DESIGN_CONTRACT_ACCEPTED_WITH_COMPETENCY_BOUNDARY`.

No competency record, procedure completion, OSCE result, checklist, credential, sign-off, canonical enum, or schema activation is created.

### Required authority

Architecture/schema authority must confirm record roles and contract semantics. Qualified relevant clinical/educational authority must separately review competency and assessment boundaries. Rights, taxonomy, audit, QA, and implementation authorities remain separate.

### Evidence basis

The contract recommendation specifies the distinction among `framework_candidate`, `individual_skill_candidate`, competency, and sign-off roles, and prohibits inference of required level, assessment method, reviewer status, or competency outcome from folders or topic labels. [3]

### Conditions

The contract must preserve the framework-versus-competency boundary, explicit level semantics, assessment method, reviewer status, record role, and any sign-off model. No educational or clinical competency conclusion may be inferred from the source package.

### Audit requirements

The audit event must record the contract identity/version when supplied, record-role decision, competency boundary, required-level and assessment semantics, reviewer status, unresolved issues, evidence links, authority, actor/role/timestamp, and explicit non-activation status.

## G) Reference / Book contract decision

### Recommendation

Accept the Reference / Book contract as a design reference with an independent rights gate. Preserve reference type, title, author/publisher or owner when evidenced, governed version, exact locator, rights, display scope, track/taxonomy, review state, source identity, and audit lineage. [3]

### Decision options

| Option | Meaning |
|---|---|
| `ACCEPT_WITH_RIGHTS_GATE` | Accept the bounded design while requiring independent rights and display-scope closure. |
| `RETURN_FOR_RIGHTS_OR_LOCATOR_CLARIFICATION` | Request missing rights, provenance, version, or locator evidence. |
| `BLOCK_PENDING_RIGHTS_AND_CONTRACT_AUTHORITY` | Keep the design blocked until the rights and contract gates close. |
| `REJECT_DESIGN_RECOMMENDATION` | Reject the recommendation with attributable rationale. |

### Selected status field

`DESIGN_CONTRACT_ACCEPTED_WITH_RIGHTS_GATE`.

No canonical `reference`/`book` enum, display authorization, schema activation, or learner-facing exposure is created.

### Required authority

Architecture/schema authority must confirm reference/book semantics and exact locator rules. An independent rights authority must decide text usage, image usage, licensing or rights, restrictions, and learner-display scope. Relevant clinical/educational review remains separate where the reference supports educational claims.

### Evidence basis

The contract recommendation states that PDF presence, filename, or folder location does not establish authorship, governed version, rights, exact page/chapter/section locator, or display scope. It requires independent provenance, version, rights, and relevant-review closure before revalidation or display consideration. [3]

### Conditions

Rights and display scope remain open or blocked until attributable evidence is supplied. No quotation, figure, table, image, derivative display, or learner-facing reference may be exposed based solely on file presence or a path.

### Audit requirements

The audit event must record reference type, source identity, version, exact locator, owner/publisher evidence, text/image rights decisions, display scope, restrictions, reviewer identities/roles when supplied, decision date, evidence links, unresolved issues, and explicit non-display status.

## 3. Cross-cutting limitations and protected boundaries

The seven design decisions above do not close the following gates: provenance and governed version, rights and display scope, qualified clinical/relevant review, explicit `02_Internship` track and taxonomy ID/version, append-only audit readiness, canonical contract confirmation, independent duplicate comparison, lineage namespace closure, QA validation, and implementation authorization. [1] [2] [3]

The following actions remain outside this Phase 6.8 decision record:

| Action | Status |
|---|---|
| Clinical approval | `NOT_GRANTED` |
| Rights approval | `NOT_GRANTED` |
| Canonical duplicate selection | `NOT_RECORDED` |
| Canonical manifest/schema amendment | `NOT_AUTHORIZED` |
| Schema conversion or revalidation execution | `NOT_AUTHORIZED` |
| JSON generation | `NOT_AUTHORIZED` |
| Database import or writes | `NOT_AUTHORIZED` |
| Application, route, authentication, or security changes | `NOT_AUTHORIZED` |
| Content activation, publication, or learner-facing exposure | `NOT_AUTHORIZED` |
| Delete, rename, merge, archive, overwrite, or replace originals | `NOT_AUTHORIZED` |
| Commit, push, deploy, or release | `NOT_PERFORMED` |

## 4. Next allowed phase

The next allowed work is controlled evidence closure against the recorded conditions. A later schema-revalidation review requires all applicable evidence gates to pass and a separate written authorization defining exact artifacts, source IDs, versions, checksums, contract/schema identity, professional track, taxonomy context, reviewer scope, output path, and non-production status. No schema-revalidation execution is authorized by this document.

## 5. Validation and non-actions

| Validation item | Result |
|---|---|
| READ_ONLY | `PASS` |
| Decision documentation only | `PASS` |
| Seven required decision sections present | `PASS` |
| Approvals invented | `FALSE` |
| Clinical review performed by this record | `FALSE` |
| Clinical approval granted | `FALSE` |
| Rights approval granted | `FALSE` |
| JSON generated | `FALSE` |
| Schema conversion/revalidation executed | `FALSE` |
| Database/application modified | `FALSE` |
| Content imported or activated | `FALSE` |
| Originals deleted, renamed, merged, archived, overwritten, or replaced | `FALSE` |
| Original lineages preserved | `PASS` |
| Commit/push/deployment performed | `FALSE` |

## References

[1]: `/home/ubuntu/seg-internship-output/SEG_INTERNSHIP_GOVERNANCE_ACCEPTANCE_CHECKLIST.md` "Phase 6.7 Governance Acceptance Checklist"  
[2]: `/home/ubuntu/seg-internship-output/SEG_INTERNSHIP_PHASE_6_7_GATE_REPORT.md` "Phase 6.7 Gate Report"  
[3]: `/home/ubuntu/seg-internship-output/SEG_INTERNSHIP_CONTENT_CONTRACT_RECOMMENDATION_STATUS.md` "Phase 6.6 Content Contract Recommendation Status"  
[4]: `/home/ubuntu/seg-internship-output/SEG_INTERNSHIP_LINEAGE_RECOMMENDATION_DECISION.md` "Phase 6.6 Lineage Recommendation Decision"  
[5]: `/home/ubuntu/seg-internship-output/SEG_INTERNSHIP_DUPLICATE_RECOMMENDATION_DECISION.md` "Phase 6.6 Duplicate Recommendation Decision"  
[6]: `/home/ubuntu/seg-internship-output/SEG_INTERNSHIP_GOVERNANCE_ACCEPTANCE_DECISION_RECORD.md` "Existing Phase 6.8 Governance Acceptance Decision Record preserved for compatibility"  
